Rebalance’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Rebalance’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-679,446	Closed	-$17.1M	–	107
2025 Q3	$17.1M	Buy	679,446 +243,134	+56%	+$6.11M	1.03%	13
2025 Q2	$11M	Buy	436,312 +6,989	+2%	+$176K	0.75%	16
2025 Q1	$10.8M	Buy	429,323 +94,318	+28%	+$2.37M	0.8%	15
2024 Q4	$8.39M	Buy	335,005 +314,887	+1,565%	+$7.89M	0.63%	17
2024 Q3	$505K	Buy	+20,118	New	+$502K	0.04%	70

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.81B AUM 21.81% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Rebalance's IBDQ Position: Q4 2025 in Review

Rebalance sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 679,446 shares — an estimated $17.1M sold.

Rebalance first reported a position in IBDQ in Q3 2024 and held it in 5 quarters. The position peaked at $17.1M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

Rebalance reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
Rebalance sold 679,446 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $17.1M.
Rebalance first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2024 and held it in 5 quarters.
Rebalance's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $17.1M in Q3 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Rebalance's 13F filing for Q4 2025, filed 15 Jan 2026.